This Clinical Practice Update integrates data from a large, randomized controlled trial (the ARRIVE trial [A Randomized Trial of Induction Versus Expectant Management]) and subsequent other related studies into existing American College of Obstetricians and Gynecologists' guidance regarding management of pregnant individuals at 39 0/7-41 6/7 weeks of gestation without a medical indication for delivery. This document updates Practice Bulletin No. 146, Management of Late-Term and Postterm Pregnancies (Obstet Gynecol 2014;124:390-396) and replaces the Clinical Guidance for Integration of the Findings of the ARRIVE Trial: Labor Versus Expectant Management in Low-Risk Nulliparous Women Practice Advisory, originally published in August 2018.

中文翻译：

---

无分娩医学指征的足月胎生个体的管理。


本临床实践更新将来自一项大型随机对照试验（ARRIVE 试验 [引产与期待管理的随机试验]）和随后的其他相关研究的数据整合到现有的美国妇产科医师学会关于妊娠 39 0/7-41 6/7 周无分娩医学指征的孕妇管理的指南中。本文件更新了第 146 号实践公报，晚期和过期妊娠的管理（Obstet Gynecol 2014;124：390-396），并取代最初于 2018 年 8 月发布的 ARRIVE 试验结果整合临床指南：低风险未产妇实践咨询中的分娩与期待管理。